FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal

WASHINGTON (Reuters) - The U.S. Federal Trade Commission said on Wednesday that German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle FTC charges that a proposed asset swap with Sanofi would harm competition.